SenesTech, Inc. Common Stock
SNESSenesTech, Inc. (SNES) is a biotechnology company that develops and commercializes products aimed at managing pest populations through reproductive control. The company is best known for its innovative use of reproductive suppression technology to address pest-related challenges in agriculture, urban settings, and beyond. Its flagship product, ContraPest, is designed to effectively reduce rodent populations by targeting their fertility, offering an environmentally friendly and humane alternative to traditional pest control methods.
Company News
SenesTech's Board of Directors approved an amendment to reduce the number of new shares proposed for its 2018 Equity Incentive Plan from 1.7 million to 1.2 million shares ahead of the June 9, 2026 Annual Meeting of Stockholders. The company cited anticipated equity compensation needs, current market conditions, and stockholder considerations in m...
SenesTech Inc (NASDAQ: SNES) announced that President and CEO Joel Fruendt plans to retire. The Board will conduct a formal search for a successor, with Fruendt remaining in his position until the search concludes or June 30, 2026, whichever comes first. Dr. Jamie Bechtel has been appointed Interim Executive Chair to support the transition, while...
SenesTech reported record quarterly revenue of $690,000, a 43% increase from the previous year, with Evolve® Rodent Birth Control product sales growing 77% and representing 85% of total revenue. The company continues to expand across e-commerce, municipal, and retail markets while maintaining a strong cash balance of $10.2 million.
SenesTech completed a warrant exercise transaction, raising approximately $6.3 million in gross proceeds through the issuance of new short-term warrants. The company plans to use the funds for working capital and general corporate purposes.
SenesTech, a company specializing in fertility control for animal pest populations, will release its Q2 2025 financial results on August 7, 2025, after market close, with a conference call scheduled for 5:00 p.m. Eastern time.
